Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation

Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Shu Pan, Joseph Burnett, Nathan A. Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao, Duxin Sun